Annual CFO
-$122.20 M
-$71.98 M-143.33%
December 31, 2024
Summary
- As of March 10, 2025, VRNA annual cash flow from operations is -$122.20 million, with the most recent change of -$71.98 million (-143.33%) on December 31, 2024.
- During the last 3 years, VRNA annual CFO has fallen by -$88.95 million (-267.48%).
- VRNA annual CFO is now -3594305.88% below its all-time high of $3400.00, reached on December 31, 2005.
Performance
VRNA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$28.84 M
+$33.82 M+53.98%
December 31, 2024
Summary
- As of March 10, 2025, VRNA quarterly cash flow from operations is -$28.84 million, with the most recent change of +$33.82 million (+53.98%) on December 31, 2024.
- Over the past year, VRNA quarterly CFO has dropped by -$18.43 million (-177.22%).
- VRNA quarterly CFO is now -226.34% below its all-time high of $22.82 million, reached on September 30, 2021.
Performance
VRNA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$122.20 M
-$18.43 M-17.76%
December 31, 2024
Summary
- As of March 10, 2025, VRNA TTM cash flow from operations is -$122.20 million, with the most recent change of -$18.43 million (-17.76%) on December 31, 2024.
- Over the past year, VRNA TTM CFO has dropped by -$71.98 million (-143.33%).
- VRNA TTM CFO is now -2672.24% below its all-time high of -$4.41 million, reached on March 31, 2017.
Performance
VRNA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VRNA Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -143.3% | -177.2% | -143.3% |
3 y3 years | -267.5% | -177.2% | -143.3% |
5 y5 years | -185.1% | -177.2% | -143.3% |
VRNA Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -267.5% | at low | -398.7% | +54.0% | -328.4% | at low |
5 y | 5-year | -267.5% | at low | -226.3% | +54.0% | -328.4% | at low |
alltime | all time | <-9999.0% | at low | -226.3% | +54.0% | -2672.2% | at low |
Verona Pharma Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | -$122.20 M(+143.3%) | -$28.84 M(-54.0%) | -$122.20 M(+17.8%) |
Sep 2024 | - | -$62.66 M(+266.4%) | -$103.77 M(+92.7%) |
Jun 2024 | - | -$17.10 M(+25.7%) | -$53.84 M(-7.3%) |
Mar 2024 | - | -$13.61 M(+30.8%) | -$58.05 M(+15.6%) |
Dec 2023 | -$50.22 M(-16.1%) | -$10.40 M(-18.3%) | -$50.22 M(+5.6%) |
Sep 2023 | - | -$12.73 M(-40.3%) | -$47.56 M(-10.1%) |
Jun 2023 | - | -$21.31 M(+268.6%) | -$52.93 M(+3.5%) |
Mar 2023 | - | -$5.78 M(-25.3%) | -$51.13 M(-14.6%) |
Dec 2022 | -$59.86 M(+80.0%) | -$7.74 M(-57.2%) | -$59.86 M(-13.8%) |
Sep 2022 | - | -$18.09 M(-7.3%) | -$69.45 M(+143.4%) |
Jun 2022 | - | -$19.52 M(+34.5%) | -$28.53 M(-2.4%) |
Mar 2022 | - | -$14.51 M(-16.2%) | -$29.21 M(-12.1%) |
Dec 2021 | -$33.25 M(-26.2%) | -$17.32 M(-175.9%) | -$33.25 M(-4.2%) |
Sep 2021 | - | $22.82 M(-213.0%) | -$34.73 M(-48.6%) |
Jun 2021 | - | -$20.20 M(+8.9%) | -$67.55 M(+34.0%) |
Mar 2021 | - | -$18.55 M(-1.3%) | -$50.40 M(+11.8%) |
Dec 2020 | -$45.08 M(+5.2%) | -$18.80 M(+88.0%) | -$45.08 M(+19.1%) |
Sep 2020 | - | -$10.00 M(+226.6%) | -$37.83 M(+4.4%) |
Jun 2020 | - | -$3.06 M(-76.9%) | -$36.24 M(-16.2%) |
Mar 2020 | - | -$13.22 M(+14.5%) | -$43.23 M(+0.8%) |
Dec 2019 | -$42.87 M | -$11.55 M(+37.5%) | -$42.87 M(+15.0%) |
Sep 2019 | - | -$8.40 M(-16.4%) | -$37.29 M(+25.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2019 | - | -$10.05 M(-21.9%) | -$29.75 M(+9.8%) |
Mar 2019 | - | -$12.86 M(+115.5%) | -$27.11 M(+17.9%) |
Dec 2018 | -$22.98 M(-17.8%) | -$5.97 M(+585.6%) | -$22.98 M(-3.6%) |
Sep 2018 | - | -$870.80 K(-88.2%) | -$23.83 M(-28.9%) |
Jun 2018 | - | -$7.40 M(-15.3%) | -$33.50 M(+3.7%) |
Mar 2018 | - | -$8.74 M(+28.1%) | -$32.30 M(+15.5%) |
Dec 2017 | -$27.97 M(+305.8%) | -$6.82 M(-35.3%) | -$27.97 M(+32.3%) |
Sep 2017 | - | -$10.54 M(+69.9%) | -$21.15 M(+99.3%) |
Jun 2017 | - | -$6.20 M(+40.7%) | -$10.61 M(+140.7%) |
Mar 2017 | - | -$4.41 M | -$4.41 M |
Dec 2016 | -$6.89 M(-26.8%) | - | - |
Dec 2015 | -$9.42 M(+70.9%) | - | - |
Dec 2014 | -$5.51 M(+62.7%) | - | - |
Dec 2013 | -$3.39 M(-17.0%) | - | - |
Dec 2012 | -$4.08 M(+67.0%) | - | - |
Dec 2011 | -$2.44 M(-4.6%) | - | - |
Dec 2010 | -$2.56 M(-2.3%) | - | - |
Dec 2009 | -$2.62 M(+32.6%) | - | - |
Dec 2008 | -$1.98 M(-17.3%) | - | - |
Dec 2007 | -$2.39 M(+247.5%) | - | - |
Dec 2006 | -$687.70 K(<-9900.0%) | - | - |
Dec 2005 | $3400.00 | - | - |
FAQ
- What is Verona Pharma annual cash flow from operations?
- What is the all time high annual CFO for Verona Pharma?
- What is Verona Pharma annual CFO year-on-year change?
- What is Verona Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Verona Pharma?
- What is Verona Pharma quarterly CFO year-on-year change?
- What is Verona Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for Verona Pharma?
- What is Verona Pharma TTM CFO year-on-year change?
What is Verona Pharma annual cash flow from operations?
The current annual CFO of VRNA is -$122.20 M
What is the all time high annual CFO for Verona Pharma?
Verona Pharma all-time high annual cash flow from operations is $3400.00
What is Verona Pharma annual CFO year-on-year change?
Over the past year, VRNA annual cash flow from operations has changed by -$71.98 M (-143.33%)
What is Verona Pharma quarterly cash flow from operations?
The current quarterly CFO of VRNA is -$28.84 M
What is the all time high quarterly CFO for Verona Pharma?
Verona Pharma all-time high quarterly cash flow from operations is $22.82 M
What is Verona Pharma quarterly CFO year-on-year change?
Over the past year, VRNA quarterly cash flow from operations has changed by -$18.43 M (-177.22%)
What is Verona Pharma TTM cash flow from operations?
The current TTM CFO of VRNA is -$122.20 M
What is the all time high TTM CFO for Verona Pharma?
Verona Pharma all-time high TTM cash flow from operations is -$4.41 M
What is Verona Pharma TTM CFO year-on-year change?
Over the past year, VRNA TTM cash flow from operations has changed by -$71.98 M (-143.33%)